受强制性开放获取政策约束的文章 - Remant KC (रेमन्त के. सी.)了解详情
无法在其他位置公开访问的文章：19 篇
pH and redox dual responsive nanoparticle for nuclear targeted drug delivery
RB KC, B Thapa, P Xu
Molecular pharmaceutics 9 (9), 2719-2729, 2012
强制性开放获取政策： US National Institutes of Health
Lipid substitution on low molecular weight (0.6–2.0 kDa) polyethylenimine leads to a higher zeta potential of plasmid DNA and enhances transgene expression
HU K.C. Remant Bahadur, Breanne Landry, Afsaneh
Acta Biomaterialia 7 (5), 2209-2217, 2011
强制性开放获取政策： Canadian Institutes of Health Research
TRAIL therapy and prospective developments for cancer treatment
B Thapa, KC Remant, H Uludağ
Journal of Controlled Release 326, 335-349, 2020
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Current outlook on drug resistance in chronic myeloid leukemia (CML) and potential therapeutic options
DNM Sundaram, X Jiang, JM Brandwein, J Valencia-Serna, KC Remant, ...
Drug Discovery Today 24 (7), 1355-1369, 2019
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
PEI and its derivatives for gene therapy
KCR Bahadur, H Uludağ
Polymers and Nanomaterials for Gene Therapy, 29, 2016
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Cholesterol grafted cationic lipopolymers: Potential siRNA carriers for selective chronic myeloid leukemia therapy
KC Remant, B Thapa, J Valencia‐Serna, SS Domun, C Dimitroff, X Jiang, ...
Journal of Biomedical Materials Research Part A 108 (3), 565-580, 2020
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
siRNA-mediated BCR-ABL silencing in primary chronic myeloid leukemia cells using lipopolymers
J Valencia-Serna, C Kucharski, M Chen, KC Remant, X Jiang, ...
Journal of Controlled Release 310, 141-154, 2019
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research …
Polymeric Delivery of siRNA against Integrin‐β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells
DN Meenakshi Sundaram, C Kucharski, MB Parmar, RB Kc, H Uludağ
Macromolecular Bioscience 17 (6), 1600430, 2017
强制性开放获取政策： Natural Sciences and Engineering Research Council of Canada
BCR-Abl Silencing by siRNA: A Potent Approach to Sensitize Chronic Myeloid Leukemia Cells to Tyrosine Kinase Inhibitor Therapy
R Kc, B Thapa, A Ubeda, X Jiang, H Uludağ
Stem Cells and Development 28 (11), 734-744, 2019
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Current attempts to implement siRNA-based RNAi in leukemia models
DME Hasan Uludağ, Breanne Landry, Juliana Valencia-Serna, K.C. Remant-Bahadur
Drug Discovery Today, 2016
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Breathing new life into TRAIL for breast cancer therapy: Co-delivery of pTRAIL and complementary siRNAs using lipopolymers
B Thapa, R Kc, M Bahniuk, J Schmitke, M Hitt, A Lavasanifar, O Kutsch, ...
Human Gene Therapy 30 (12), 1531-1546, 2019
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Biomaterials to facilitate delivery of RNA agents in bone regeneration and repair
EK Tsekoura, RB KC, H Uludag
ACS Biomaterials Science & Engineering 3 (7), 1195-1206, 2017
强制性开放获取政策： Natural Sciences and Engineering Research Council of Canada
In vitro cytotoxicity and cytokine production by lipid-substituted low molecular weight branched PEIs used for gene delivery
DNM Sundaram, S Plianwong, KC Remant, H Ostergaard, H Uludağ
Acta Biomaterialia 148, 279-297, 2022
强制性开放获取政策： Bill & Melinda Gates Foundation, Canadian Institutes of Health Research …
Transfection efficacy and cellular uptake of lipid-modified polyethyleneimine derivatives for anionic nanoparticles as gene delivery vectors
AP Rajendran, O Ogundana, LC Morales, DN Meenakshi Sundaram, ...
ACS Applied Bio Materials 6 (3), 1105-1121, 2023
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Investigation of water‐insoluble hydrophobic polyethylenimines as RNAi vehicles in chronic myeloid leukemia therapy
AS Ansari, R KC, X Jiang, H Uludaǧ
Journal of Biomedical Materials Research Part A 109 (11), 2306-2321, 2021
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models
AS Ansari, KC Remant, LC Morales, M Nasrullah, DNM Sundaram, ...
Journal of Controlled Release 367, 821-836, 2024
强制性开放获取政策： Alex's Lemonade Stand
Biodistribution of Therapeutic Small Interfering RNAs Delivered with Lipid-Substituted Polyethylenimine-Based Delivery Systems
LC Morales, A Rajendran, A Ansari, R Kc, M Nasrullah, K Kiti, ...
Molecular Pharmaceutics 21 (3), 1436-1449, 2024
强制性开放获取政策： Canadian Institutes of Health Research, Alex's Lemonade Stand
TRAIL therapy for breast cancer treatment by employing lipopolymer mRNA delivery
B Thapa, R KC, X Liu, W Fu, DW Seol, H Uludağ
GEN Biotechnology 1 (1), 101-112, 2022
强制性开放获取政策： Canadian Institutes of Health Research, Natural Sciences and Engineering …
An optimized polymeric delivery system for piggyBac transposition
DN Meenakshi Sundaram, R Bahadur KC, W Fu, H Uludağ
Biotechnology and Bioengineering 121 (5), 1503-1517, 2024
强制性开放获取政策： Bill & Melinda Gates Foundation
可在其他位置公开访问的文章：23 篇
Aliphatic lipid substitution on 2 kDa polyethylenimine improves plasmid delivery and transgene expression
A Neamnark, O Suwantong, RB KC, CYM Hsu, P Supaphol, H Uludag
Molecular Pharmaceutics 6 (6), 1798-1815, 2009
强制性开放获取政策： Canadian Institutes of Health Research
出版信息和资助信息由计算机程序自动确定